Skip to main content

Day: August 18, 2021

Hanmi Announces Pricing of $110 Million Subordinated Debt Offering

LOS ANGELES, Aug. 18, 2021 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC) (“Hanmi”), the holding company for Hanmi Bank (the “Bank”), today announced that it has priced an underwritten public offering of $110 million aggregate principal amount of its fixed-to-floating rate subordinated notes (the “Notes”) due 2031. The Notes will initially bear a fixed interest rate of 3.750% per year. Commencing on September 1, 2026, the interest rate on the Notes resets quarterly to the three-month SOFR rate plus a spread of 310 basis points, payable quarterly in arrears. The offering is expected to close on August 20, 2021, subject to the satisfaction of customary closing conditions.   The Company plans to use the net proceeds from the Notes offering for general corporate purposes, which may include refinancing activities, including...

Continue reading

Vallourec: Availability of information relating to the Combined (Ordinary and Extraordinary) Shareholders’ Meeting of September 7, 2021

Availability of information relating to the Combined (Ordinary and Extraordinary) Shareholders’ Meeting of September 7, 2021 Boulogne-Billancourt (France), August 18, 2021 – Vallourec’s Ordinary and Extraordinary Shareholders’ Meeting will be held on Tuesday 7 September, 2021, at 2:00 p.m. at Espace Verso, 52 rue de la Victoire, in Paris. The preliminary notice of meeting published in the Bulletin des Annonces Légales Obligatoires of August 2, 2021, the notice of meeting brochure including the agenda, draft resolutions and reports thereon, as well as the procedures for participating in the Meeting and voting are available on Vallourec’s website (www.vallourec.com). The documents and information about the Shareholders’ Meeting will be available to shareholders, in accordance with the prevailing regulations, at Vallourec’s...

Continue reading

The Onex Group Completes Final Sale of JELD-WEN

All amounts in U.S. dollars unless otherwise stated TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced Onex Partners III (the “Fund”) and certain co-investors, including Onex (together the “Onex Group”), have completed the sale of their remaining approximately 14.9 million shares of JELD-WEN Holding, Inc. (“JELD-WEN”) (NYSE: JELD) common stock at a net price of $28.50 per share. JELD-WEN is one of the world’s largest door and window manufacturers. With this sale, the Onex Group no longer holds any shares of JELD-WEN. Gross proceeds to the Onex Group from this transaction are approximately $425 million, of which Onex’ share was approximately $110 million as a Limited Partner in the Fund and as a co-investor. On March 1, 2021, a registration statement including a prospectus (File...

Continue reading

Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System

BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity Imprint, available in both cruciate retaining (CR) and posterior stabilized (PS) implants, utilizes a proprietary algorithm to select the implant size that most closely meets the geometric and anatomic requirements of the patient’s knee based on the individual’s CT scan. As with Conformis’ personalized iTotal® knee product line, Identity Imprint uses Conformis’ sterile Surgery-in-a-Box™ delivery system, which provides ambulatory surgical centers (ASCs) and hospitals greater procedural efficiency and improved sterilization cost savings over comparable systems. The first surgery was successfully performed by Dr. Moby Parsons at Stratham Ambulatory...

Continue reading

Ashland Global Holdings Inc. announces completion of senior notes offering by Ashland LLC

WILMINGTON, Del., Aug. 18, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) announced today that its indirect, wholly owned subsidiary, Ashland LLC, has closed its previously announced offering of $450 million aggregate principal amount of 3.375 percent senior notes due 2031 (the “Notes”). The Notes are senior unsecured obligations of Ashland LLC. The Notes are initially guaranteed on an unsecured basis by Ashland Global Holdings Inc. (the “Guarantee”). Ashland intends to use the net proceeds of the offering, after deducting initial purchasers’ discounts and other fees and expenses, to redeem its obligations under its outstanding 4.750 percent senior notes due 2022, and to pay any premiums, penalties, fees and expenses associated therewith (the “Refinancing”), with any remaining net proceeds to be held as cash...

Continue reading

Genasys Inc. Appoints Susan Lee and Caltha Seymour to Board of Directors

SAN DIEGO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions, today announced Susan Lee and Caltha Seymour have been appointed to the Company’s Board of Directors (Board) effective September 1, 2021. “We welcome Ms. Lee and Ms. Seymour to the Company’s Board,” said Richard Danforth, Chief Executive Officer of Genasys Inc. “They each bring extensive senior executive experience from diverse business backgrounds that will be most beneficial in expanding our worldwide business and increasing shareholder value.” Ms. Lee brings more than 20 years of experience in digital marketing software, media, data analytics, and strategic partnerships to the Board. Lee currently serves as Group President of Digital Marketing & Technology...

Continue reading

KemPharm Appoints Tamara A. Seymour to Board of Directors

CELEBRATION, Fla., Aug. 18, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today the appointment of Tamara A. Seymour to serve on its Board of Directors and as Chair of the Audit Committee. Ms. Seymour brings to KemPharm more than 30 years of life sciences industry experience, including 20 years in the role of chief financial officer. She currently serves as a board member and audit committee chair of Artelo Biosciences, Inc. and Kintara Therapeutics, Inc., both publicly-traded clinical-stage biopharmaceutical companies. “The addition of Tamara to our Board of Directors and her appointment as Chair of the Audit Committee comes at an important phase in the evolution of KemPharm and continues what has been a transformative...

Continue reading

AirBoss Strengthens North American Rubber Compounding Positioning Through Acquisition of Ace Elastomer

NEWMARKET, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) (the “Company” or “AirBoss”) is pleased to announce that it has agreed to acquire 100% ownership of Ace Elastomer, Inc. (“Ace”) (the “Agreement”), a leading custom rubber compounder with facilities in Rock Hill, South Carolina and Chicago, IL. Pursuant to the Agreement, AirBoss Rubber Solutions (“ARS”) will acquire Ace for approximately US$42.5 million, to be satisfied in cash upon closing. The transaction is subject to customary closing conditions and is expected to close during the third quarter of 2021. Ace’s President, founder and majority owner, Russell Foster, and the existing management team will all remain with Ace in their current capacities following the closing of the acquisition. Strategic Rationale:Increases ARS’...

Continue reading

ORBCOMM Announces FCC Approval of Acquisition by GI Partners

Transaction On Track to Close in early September 2021 ROCHELLE PARK, N.J., Aug. 18, 2021 (GLOBE NEWSWIRE) — ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Internet of Things (IoT) solutions, today announced that the Federal Communications Commission (FCC) has approved the transfer of control of ORBCOMM’s FCC authorizations in connection with the previously announced acquisition of ORBCOMM by GI Partners, a leading US-based investor in data infrastructure businesses. The FCC’s approval satisfies one of the conditions to the closing of the proposed acquisition, which remains subject to other customary closing conditions. Subject to satisfaction of those conditions, the transaction is expected to be completed by early September of 2021. Upon completion of the proposed acquisition, ORBCOMM will become a privately-held company, and...

Continue reading

Lifeway Foods Completes Acquisition of Certain GlenOaks Farms’ Assets

Acquires Certain Assets of California-Based Probiotic Drinkable Yogurt Brand to Capitalize on Demand for Local Brands in the WestLifeway to Acquire Certain Assets of GlenOaks FarmsLifeway Foods CEO Julie Smolyansky with GlenOaks Farms drinkable yogurtMORTON GROVE, Ill., Aug. 18, 2021 (GLOBE NEWSWIRE) — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced today that it has completed the acquisition of certain assets of the privately-held, California-based GlenOaks Farms, Inc., a respected and pioneering probiotic drinkable yogurt brand founded in 1984. The all-cash transaction is for certain GlenOaks Farms assets with a purchase price of $5.8m subject to other adjustments as provided by the agreement....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.